Life science, also referred to as biology, is the study of life and living things. It includes anatomy, animal biology, bacteriology, biochemistry, cell biology, ecology, evolutionary biology, genetics, molecular biology, plant biology, physiology, and virology. Life science plays a major role in drug discovery, tissue engineering, drug screening, forensic testing, and genetic analysis. The life sciences industry consists of companies operating in the fields of pharmaceuticals, biotechnology, medical devices, biomedical technologies, nutraceuticals, cosmeceuticals, food processing, and others that dedicate their efforts to creating products to improve the lives of organisms. Life sciences products, including reagents, assays, antibodies, immunoassays, and more. Dedicated Fisher Scientific life sciences specialists are ready to help you find the research products and supplies you need for your molecular biology, cell biology, and protein purification. Life Sciences cater to the research and discovery of living organisms and include areas of study such as Agricultural and Biological Sciences, Immunology, and Neuroscience.
Market Dynamics
Major players in the market are also focused on conducting clinical trials to expand their product portfolio. For instance, in March 2020, Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, presented additional analyses from the ORCA-1 Phase 2b trial that assessed the efficacy of ‘Cytisinicline’, a plant-based alkaloid with a high binding affinity to the α4β2 nicotine receptor, at the SRNT Annual Meeting in New Orleans. Moreover, an increase in the adoption of inorganic growth strategies such as partnerships is expected to drive the growth of the market over the forecast period. For instance, in October 2021, Leinco Technologies, Inc., a contract development manufacturing organization (CDMO), and Vanderbilt University, based in U.S., announced a partnership that will give Leinco exclusive rights to increase antibody production at the center for infectious disease clinical research, diagnostics, therapeutics, and vaccine development.
Key features of the study:
- This report provides an in-depth analysis of the global life science products market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2023–2030), considering 2022 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global life science products market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Abcam Plc, A.M.S. Biotechnology (Europe) Limited, Bio-Rad Laboratories Inc., BPS Bioscience Inc, Crown Bioscience Inc., Genscript Biotech Corporation, Merck Millipore Limited, PerkinElmer Inc, Sigma Aldrich Corp, Thermo Fisher Scientific Inc., Danaher Corporation, Amgen Inc, Lantern Pharma Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global life science products market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global life science products market
Detailed Segmentation:
- Global Life Science Products Market, By Product Type:
- Recombinant Proteins
- Immune Checkpoint Regulators
- Chemokines
- Growth Factors
- Cytokines
- Colony Stimulating Factors
- Hormones
- Enzymes & Inhibitors
- Others
- Cell Lines
- Immunotherapy Cell Lines
- Ion Channel Cell Lines
- GPCR Cell Lines
- Cell Signaling Pathway Cell Lines
- Gene Knockout Cell Lines
- Cancer Cell Lines
- Others
- Antibodies
- Immune Checkpoint Antibodies
- Epitope Tag Antibodies
- Isotype Control Antibodies
- Research Use
- In-vivo Grade
- Primary Antibodies
- Research Use
- In-vivo Grade
- Assay Antibodies (includes secondary antibodies)
- Others
- Global Life Science Products Market, By Application:
- Drug Discovery & Development
- Basic Research
- Toxicity Screening
- Biopharmaceutical Production
- Drug Screening
- Tissue Engineering
- Forensic Testing
- Global Life Science Products Market, By End User:
- Biopharmaceutical Companies
- Contract Research Organizations (CROs)
- Academic & Research Institutes
- Forensic Science Laboratories
- Diagnostic Centers
- Others
- Global Life Science Products Market, By Region:
- North America
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
- Company Profiles
- Abcam Plc*
- M.S. Biotechnology (Europe) Limited
- Bio-Rad Laboratories Inc.
- BPS Bioscience Inc
- Crown Bioscience Inc.
- Genscript Biotech Corporation
- Merck Millipore Limited
- PerkinElmer Inc
- Sigma Aldrich Corp
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Amgen Inc
- Lantern Pharma Inc
